Brief report · 29 Dec 2025
Conference abstractPublished 15 Apr 2014
Beneficial effects of myeloid-cell-expressed S100A9 in kidney transplantation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
O ur goal is to enhance diagnostic accuracy of acute rejection (AR) after kidney transplantation, and to predict the impact of AR on graft outcome. In patients suffering from AR (n=28) we identified by microarray S100A9 expression as a prognostic indicator of outcome. In a second cohort, we confirmed that patients with high S100A9 expression during AR (n=36) have better 12-year graft survival (91.5%) than low expressers (n=61; 69.2%). Furthermore, by comparing AR biopsy samples and biopsies without signs of rejection (n=120), we found that S100A9 may function as a diagnostic marker of acute rejection. Next, we studied the mechanism by which S100A9 exerts its biologic effects. In the biopsies, the majority (75%) of the S100A9+ cell population consisted of CD68+ myeloid cells expressing HLA-DR. Expression of S100A9 was related to expression of immune regulatory molecules, including IL-10, regulatory T cell marker FoxP3/CD3, and p40 component of the reactive oxygen species (ROS)-producing machinery. Overexpression of S100A9 in cultured macrophages led to increased ROS production, whereas inhibition by siRNA transfection resulted into decreased ROS production. The presence of low concentrations of the ROS metabolite H 2 O 2 for 0.5h led to downregulation of the proliferative response of activated T cells. S100A9 levels in the graft are specifically elevated during conditions of increased inflammation. The presence of distinct myeloid cell subsets, expressing S100A9, early after transplantation provides prognostic information with respect to graft survival. The current data suggest that an increased expression of S100A9 by myeloid cells leads to local ROS production in the immune synapse, and as a consequence downregulation of alloimmune responses by T cells in the graft
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “M. Eikmans”
- BylineArticles whose byline prints “N. V. Rekers”
- BylineArticles whose byline prints “I. M. Bajema”
- BylineArticles whose byline prints “M. Mallat”
- BylineArticles whose byline prints “J. D. H. Anholts”
- BylineArticles whose byline prints “G. M. J. S. Swings”
- BylineArticles whose byline prints “P. P. M. C. van Miert”
- BylineArticles whose byline prints “C. Kerkhoff”
